• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾髓质癌对放疗的反应。

Response to radiation in renal medullary carcinoma.

作者信息

Walsh Alexandra M, Fiveash John B, Reddy Alyssa T, Friedman Gregory K

机构信息

Division of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL;

出版信息

Rare Tumors. 2011 Jul 11;3(3):e32. doi: 10.4081/rt.2011.e32. Epub 2011 Jul 21.

DOI:10.4081/rt.2011.e32
PMID:22066039
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3208419/
Abstract

Renal medullary carcinoma (RMC) is a rare and highly aggressive malignancy arising from the renal medulla and found mostly in patients with sickle cell trait. RMC usually presents with widely metastatic disease. We describe a young man diagnosed with metastatic RMC who sustained a complete response to systemic chemotherapy but developed brain metastases with leptomeningeal involvement and subsequently had a partial response to brain irradiation. The use of radiation in the management of RMC is reviewed. Due to the apparent propensity for RMC to spread to the central nervous system, prophylactic treatment such as craniospinal irradiation should be considered along with chemotherapy in patients with metastatic RMC to potentially improve the progression-free interval.

摘要

肾髓质癌(RMC)是一种罕见且侵袭性很强的恶性肿瘤,起源于肾髓质,多见于具有镰状细胞特征的患者。RMC通常表现为广泛转移的疾病。我们描述了一名被诊断为转移性RMC的年轻男性,他对全身化疗产生了完全缓解,但出现了伴有软脑膜受累的脑转移,随后对脑部放疗产生了部分缓解。本文回顾了放疗在RMC治疗中的应用。鉴于RMC明显有扩散至中枢神经系统的倾向,对于转移性RMC患者,在化疗的同时应考虑进行预防性治疗,如全脑脊髓放疗,以潜在地改善无进展生存期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0b/3208419/e78d659bcab1/rt-2011-3-e32-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0b/3208419/e78d659bcab1/rt-2011-3-e32-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce0b/3208419/e78d659bcab1/rt-2011-3-e32-g001.jpg

相似文献

1
Response to radiation in renal medullary carcinoma.肾髓质癌对放疗的反应。
Rare Tumors. 2011 Jul 11;3(3):e32. doi: 10.4081/rt.2011.e32. Epub 2011 Jul 21.
2
Clinical Characteristics, Management, and Outcomes of Patients with Renal Medullary Carcinoma: A Single-center Retrospective Analysis of 135 Patients.肾髓质癌患者的临床特征、治疗及预后:135例患者的单中心回顾性分析
Eur Urol Oncol. 2025 Apr;8(2):315-323. doi: 10.1016/j.euo.2024.07.002. Epub 2024 Jul 15.
3
Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, Doxorubicin, and Cisplatin chemotherapy.肾髓质癌:一例侵袭性恶性肿瘤病例报告,对剂量密集型甲氨蝶呤、长春碱、阿霉素和顺铂化疗接近完全缓解
Case Rep Oncol Med. 2014;2014:615895. doi: 10.1155/2014/615895. Epub 2014 Aug 19.
4
Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil.肾髓质癌对化疗的反应:巴西一家转诊中心的经验
Rare Tumors. 2013 Aug 20;5(3):e44. doi: 10.4081/rt.2013.e44. eCollection 2013.
5
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary Carcinoma.肾髓质癌患者的诊断、治疗和临床试验资格标准的更新建议。
Clin Genitourin Cancer. 2019 Feb;17(1):1-6. doi: 10.1016/j.clgc.2018.09.005. Epub 2018 Sep 12.
6
Renal Medullary Carcinoma in an Adolescent With Unknown Sickle Cell Trait.一名患有未知镰状细胞性状的青少年的肾髓质癌
Cureus. 2021 Apr 13;13(4):e14473. doi: 10.7759/cureus.14473.
7
Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.肾细胞癌,未分类,具有髓样表型:与肾髓样癌重叠的低分化腺癌。
Hum Pathol. 2017 Sep;67:134-145. doi: 10.1016/j.humpath.2017.07.006. Epub 2017 Jul 15.
8
Renal Medullary Carcinoma and Sickle Cell Trait: A Push for Early Diagnosis and Intervention Report of Two Cases.肾髓质癌合并镰状细胞特征:推动早期诊断和干预的报告 两例报告。
J Natl Med Assoc. 2017;109(1):63-65. doi: 10.1016/j.jnma.2016.08.006. Epub 2016 Sep 7.
9
Renal medullary carcinoma with an ophthalmic metastasis.伴有眼部转移的肾髓质癌。
Urol Ann. 2017 Apr-Jun;9(2):184-187. doi: 10.4103/0974-7796.204184.
10
Renal medullary carcinoma in a white adolescent with sickle cell trait.一名患有镰状细胞性状的白人青少年患肾髓质癌。
J Pediatr Hematol Oncol. 2014 Jul;36(5):e285-9. doi: 10.1097/MPH.0000000000000118.

引用本文的文献

1
Sickle cell disease induces chromatin introversion and ferroptosis in CD8 T cells to suppress anti-tumor immunity.镰状细胞病诱导CD8 T细胞中的染色质内陷和铁死亡以抑制抗肿瘤免疫。
Immunity. 2025 Jun 10;58(6):1484-1501.e11. doi: 10.1016/j.immuni.2025.04.020. Epub 2025 May 12.
2
A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis.肾髓质癌脑转移中胶质细胞转分化的一例新病例。
Acta Neuropathol Commun. 2025 Jan 20;13(1):12. doi: 10.1186/s40478-025-01929-w.
3
Recent Advances in Renal Medullary Carcinoma.

本文引用的文献

1
Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma.晚期转移性肾髓质癌患者对卡铂、吉西他滨和紫杉醇完全缓解。
Pediatr Blood Cancer. 2010 Dec 1;55(6):1217-20. doi: 10.1002/pbc.22611.
2
Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms.局限期小细胞肺癌:当前的放化疗治疗模式。
Oncologist. 2010;15(2):187-95. doi: 10.1634/theoncologist.2009-0298. Epub 2010 Feb 9.
3
Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.
肾髓质癌的最新进展。
Int J Mol Sci. 2022 Jun 26;23(13):7097. doi: 10.3390/ijms23137097.
4
Sarcomatoid Renal Cell Carcinoma in an Adolescent with Sickle Cell Anaemia.一名患有镰状细胞贫血的青少年的肉瘤样肾细胞癌。
Case Rep Oncol Med. 2017;2017:2129450. doi: 10.1155/2017/2129450. Epub 2017 Oct 31.
5
Clinical and computed tomography imaging features of renal medullary carcinoma: A report of six cases.肾髓质癌的临床及计算机断层扫描影像特征:6例报告
Oncol Lett. 2016 Jan;11(1):261-266. doi: 10.3892/ol.2015.3891. Epub 2015 Nov 9.
肾髓质癌:拓扑异构酶抑制治疗的分子、病理和临床证据。
BJU Int. 2010 Jul;106(1):62-5. doi: 10.1111/j.1464-410X.2009.09139.x. Epub 2009 Dec 11.
4
Central nervous system disease in hematologic malignancies: historical perspective and practical applications.血液系统恶性肿瘤中的中枢神经系统疾病:历史回顾与实际应用
Semin Oncol. 2009 Aug;36(4 Suppl 2):S2-S16. doi: 10.1053/j.seminoncol.2009.05.002.
5
High-dose-intensity MVAC for Advanced Renal Medullary Carcinoma: Report of Three Cases and Literature Review.
Urology. 2008 Sep;72(3):659-63. doi: 10.1016/j.urology.2008.05.009. Epub 2008 Jul 23.
6
Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior.肾髓质癌:横纹肌样特征及INI1表达缺失作为侵袭性行为的标志物
Mod Pathol. 2008 Jun;21(6):647-52. doi: 10.1038/modpathol.2008.44. Epub 2008 Mar 7.
7
Renal medullary carcinoma: the Bronx experience.肾髓质癌:布朗克斯区的经验。
Urology. 2007 Nov;70(5):878-82. doi: 10.1016/j.urology.2007.06.1124.
8
Renal medullary carcinoma: report of seven cases from Brazil.肾髓质癌:来自巴西的7例报告。
Mod Pathol. 2007 Sep;20(9):914-20. doi: 10.1038/modpathol.3800934. Epub 2007 Jul 20.
9
Response to paclitaxel, gemcitabine, and cisplatin in renal medullary carcinoma.肾髓质癌对紫杉醇、吉西他滨和顺铂的反应。
Pediatr Blood Cancer. 2006 Aug;47(2):228. doi: 10.1002/pbc.20780.
10
Renal medullary carcinoma and ABL gene amplification.肾髓质癌与ABL基因扩增
J Urol. 2005 Jun;173(6):1883-8. doi: 10.1097/01.ju.0000158448.56888.09.